Patents by Inventor Takahiro AKAISHI

Takahiro AKAISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10940144
    Abstract: The present invention aims to find a novel pharmaceutical use of omidenepag, esters thereof, or salts thereof. The present inventors have made intensive studies to find a novel pharmaceutical use of omidenepag, an ester thereof, or a salt thereof, and have found as a result that omidenepag, an ester thereof, or a salt thereof significantly dilates retinal blood vessels, and significantly increases blood flow. Therefore, omidenepag, an ester thereof, or a salt thereof is expected to protect retinal nerve cells and be useful for prevention and/or treatment of ophthalmic diseases involving retinal nerve cell disorder.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: March 9, 2021
    Assignee: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Takazumi Taniguchi, Takahiro Akaishi, Hitoshi Nakazawa
  • Publication number: 20200188377
    Abstract: The present invention aims to find a novel pharmaceutical use of omidenepag, esters thereof, or salts thereof. The present inventors have made intensive studies to find a novel pharmaceutical use of omidenepag, an ester thereof, or a salt thereof, and have found as a result that omidenepag, an ester thereof, or a salt thereof significantly dilates retinal blood vessels, and significantly increases blood flow. Therefore, omidenepag, an ester thereof, or a salt thereof is expected to protect retinal nerve cells and be useful for prevention and/or treatment of ophthalmic diseases involving retinal nerve cell disorder.
    Type: Application
    Filed: September 27, 2018
    Publication date: June 18, 2020
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: TAKAZUMI TANIGUCHI, Takahiro AKAISHI, Hitoshi NAKAZAWA